JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

Inicio・Lista de Acciones・CorMedix Inc

CorMedix Inc

Cerrado

SectorSanidad

7.77 -3.36

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

7.66

Máximo

8.1

Métricas clave
By Trading Economics
Ingresos	89M 109M
Ventas	65M 104M
P/B Media del Sector	3.511 90.422
Margen de beneficios	104.112
Empleados	64
EBITDA	37M 57M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+83.87% upside

Dividendos
By Dow Jones
Próximas Ganancias	24 mar 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-257M 611M
Apertura anterior	11.13
Cierre anterior	7.77

Noticias sobre sentimiento de mercado

By Acuity

43%

57%

127 / 352 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

9.2 / N/A Soporte y Resistencia

CorMedix Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

30 ene 2026, 20:14 UTC

Adquisiciones, fusiones, absorciones

Reddy Ice to Buy Arctic Glacier, DOJ Requires Certain Divestitures

30 ene 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

Negotiations Over $100B OpenAI, Nvidia Deal Stall -- WSJ

30 ene 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

Nvidia, OpenAI in Talks to Revise Nature of Broader Partnership, Sources Say -- WSJ

30 ene 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

Nvidia CEO Jensen Huang Has Privately Told Colleagues That Deal Is Non-Binding, Sources Say -- WSJ

30 ene 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

Nvidia's Huang Has Privately Criticized OpenAI's Business Strategy, Sources Say -- WSJ

30 ene 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

OpenAI, Nvidia Deal Talks Stalled in Recent Months, Sources Say -- WSJ

30 ene 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

Nvidia's Huang Expressed Concerns Over Competition OpenAI Faces From Anthropic, Google, Sources Say -- WSJ

30 ene 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

Nvidia Weighing Equity Investment of Tens of Billions of Dollars Into OpenAI, Sources Say -- WSJ

30 ene 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

Negotiations Over $100B OpenAI, Nvidia Deal Stall, Sources Say -- WSJ

30 ene 2026, 23:41 UTC

Charlas de Mercado

Deckers Outdoor Seen as Undervalued -- Market Talk

30 ene 2026, 23:12 UTC

Adquisiciones, fusiones, absorciones

Supreme Court of British Columbia Approves Fortescue Purchase of Alta Copper

30 ene 2026, 22:20 UTC

Ganancias

Verizon Posts Strong Subscriber Gains Under New CEO -- WSJ

30 ene 2026, 22:10 UTC

Charlas de Mercado

Disney CEO's Exit Plan Marks Abrupt End to Messy Succession -- Market Talk

30 ene 2026, 21:50 UTC

Charlas de Mercado

Ganancias

Tech, Media & Telecom Roundup: Market Talk

30 ene 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

30 ene 2026, 21:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

30 ene 2026, 21:42 UTC

Ganancias

These Stocks Are Today's Movers: Apple, Verizon, SoFi, Sandisk, Western Digital, Unity Software, Exxon, and More -- Barrons.com

30 ene 2026, 21:36 UTC

Ganancias

GE Aerospace and GE Vernova Issue Their Annual Reports. They Contain Messages for Investors. -- Barrons.com

30 ene 2026, 21:33 UTC

Ganancias

Tesla Stock Rebounds From Earnings Dip. SpaceX Is Helping. -- Barrons.com

30 ene 2026, 20:42 UTC

Ganancias

These Stocks Are Today's Movers: Apple, Verizon, SoFi, Sandisk, Western Digital, Unity Software, Exxon, and More -- Barrons.com

30 ene 2026, 20:37 UTC

Adquisiciones, fusiones, absorciones

Why a Ruling Over CK Hutchison's Panama Canal Ports Matters -- and What's Next -- WSJ

30 ene 2026, 20:20 UTC

Charlas de Mercado

Oil Posts Weekly Gains on U.S.-Iran Tensions -- Market Talk

30 ene 2026, 20:13 UTC

Charlas de Mercado

U.S. Natural Gas Futures Rise on Weather-Driven Demand -- Market Talk

30 ene 2026, 19:52 UTC

Ganancias

Visa and Amex Results Point to a Strong Holiday Season for Retailers -- Barrons.com

30 ene 2026, 19:29 UTC

Charlas de Mercado

Ganancias

KLA Guidance Only 'Tepid' as Memory Rally Favors Peers -- Market Talk

30 ene 2026, 19:09 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

30 ene 2026, 19:09 UTC

Charlas de Mercado

Next Canadian Inflation Release Pushed Back a Day to Not Clash With Holiday -- Market Talk

30 ene 2026, 19:07 UTC

Charlas de Mercado

Canada Performing Well Below Economic Potential -- Market Talk

30 ene 2026, 18:46 UTC

Ganancias

'All Boats Are Rising' in Data and Memory, Says Western Digital's CFO. Just Look at the Stocks. -- Barrons.com

30 ene 2026, 18:34 UTC

Ganancias

Exxon, Chevron Post Slimmest Annual Profits Since 2021 -- 2nd Update

Comparación entre iguales

Cambio de precio

CorMedix Inc previsión

Precio Objetivo

By TipRanks

83.87% repunte

Estimación a 12 Meses

Media 14.25 USD 83.87%

Máximo 16 USD

Mínimo 13 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para CorMedix Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

4 ratings

Comprar

Mantener

Vender

De acuerdo con 4 analistas que ofrecen calificaciones bursátiles a para CorMedix Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

9.2 / N/ASoporte y Resistencia

Recent bullish events outweigh bearish events.

All events are bullish.

Sentimiento

By Acuity

127 / 352 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.